Skip to content

Ultragenyx Pharmaceutical

US · RARE #3012 by market cap Listed 1970
14.89 +0.43 +2.97%
Live - 5344 symbols - heartbeat 26s ago · 2026-10-08 07:08
Pre-market 14.63 -1.73%
After-hours 14.85 -0.27%
Overnight 14.89 0.00%
Market cap
1.47B
P/B
-5.04
EPS
-5.83
Reader sentiment Are you bullish or bearish on RARE?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Goldman Sachs Maintains LYNAS RARE EARTHS LTD(LYSCF.US) With Buy Rating
    Market Newswire · 2026/10/4
  • Company notice
    Rare Element Resources Ltd. | 3: Initial statement of beneficial ownership of securities- Bilant Josef
    SEC · 2026/10/6
  • Rating change
    Ord Minnett Maintains LYNAS RARE EARTHS LTD(LYSCF.US) With Sell Rating, Cuts Target Price to $9.82
    Market Newswire · 2026/9/29
  • CSL Strikes US$1.6 Billion Licensing Deal for Rare Disease Drug | ASX:CSL
    Proactive Investors · 2026/10/5
  • Mobix Labs Merger Partner Special Project Delivery To Combine With U.S. Rare Earth Company Winner Water Services; Terms Not Disclosed
    Benzinga · 2026/10/5
  • Ord Minnett Upgrades LYNAS RARE EARTHS LTD(LYSCF.US) to Buy Rating, Raises Target Price to $9.76
    Market Newswire · 2026/10/5
  • Bond Selloff Is Opening up Rare Opportunities for Investors. Here Is Where to Look, Says Major Bank.
    MarketWatch · 2026/10/5
  • Rating change
    J.P. Morgan Maintains LYNAS RARE EARTHS LTD(LYSCF.US) With Buy Rating, Cuts Target Price to $13.17
    Market Newswire · 2026/10/3
  • Company notice
    American Rare Earths Ltd: CSM Study Strengthens Foundation for U.S. REE Supply
    ASX · 2026/9/30
  • Rating change
    UBS Maintains LYNAS RARE EARTHS LTD(LYSCF.US) With Buy Rating, Cuts Target Price to $14.55
    Market Newswire · 2026/10/2
  • Lynas Rare Earths Price Target Cut 10% to A$18.00/Share by Jefferies
    Dow Jones · 2026/10/5
  • Rating change
    William Blair Maintains LYNAS RARE EARTHS LTD SPON ADR EACH REP 1 ORD SHS(LYSDY.US) With Buy Rating
    Market Newswire · 2026/10/1
  • Company notice
    Shionogi: Shionogi Continues Rare Disease Expansion With Planned Acquisition of IntraBio Inc.
    JPX · 2026/10/5
  • Rating change
    H.C. Wainwright Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Cuts Target Price to $25
    Market Newswire · 2026/9/25
  • Rating change
    Lynas Rare Earths Price Target Cut 5% T0 A$19.00/Share by Macquarie
    Dow Jones · 2026/10/2
  • Rating change
    Lynas Rare Earths Price Target Cut 6.7% to A$21.00/Share by UBS
    Dow Jones · 2026/10/2
  • Rating change
    J.P. Morgan Remains a Buy on Lynas Rare Earths (LYSCF)
    TipRanks · 2026/10/3
  • Company notice
    JX Advanced Metals: Notice Regarding the Agreement on a Joint Study for Entering the Rare Earth Refining Business with Tronox Co., Ltd.
    JPX · 2026/9/29
  • Rating change
    Macquarie Maintains AMERICAN RARE EARTHS LTD(ARRNF.US) With Buy Rating, Cuts Target Price to $0.38
    Market Newswire · 2026/10/1
  • Company notice
    Xiamen Tungsten Co., Ltd.: Notice Regarding the Acceptance of the Application for a Public Offering of Shares and Listing on the Beijing Stock Exchange by Its Controlling Subsidiary, Jinlong Rare Earth
    SZSI · 2026/10/1

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 07:08:01 · For reference only, not investment advice and not tailored to your situation.